The ecto-nucleoside pyrophosphatase phosphodiesterase 1 (NPP1/PC-1) is a member of the NPP enzyme family critical in regulating mineralization. In certain mineralizing sites of bone and cartilage, membrane-limited vesicles (matrix vesicles: MVs) provide a sheltered internal environment for nucleation of calcium-containing crystals including hydroxyapatite (HA).
INTRODUCTION
Three members of the nucleotide pyrophosphatase phosphodiesterase (NPP) ectoenzyme family with PP i -generating capacity (EC 3.1.4.1) are expressed in osteoblasts and chondrocytes: NPP1/PC-1, NPP2 (also referred to as autotaxin) and NPP3 (also referred to as B10/PDNP3 or gp130 ) (reviewed in 7, 13, 14) . Of these members of the NPP family, NPP1
is the first to be demonstrated to have a unique role in regulating mineralization, as disorders of spontaneous pathologic calcification have been characterized in NPP1-deficient humans (36, 37) and mice (34, 38) .
Physiological calcification within bone, cartilage and dentin is regulated by the capacity of resident cells to release vesicles that are commonly termed MVs (2, 3) . These calcificationcompetent cells employ MVs to modify the organization and composition of the extracellular matrix (2, 3) . MVs serve to modulate matrix mineralization, a process in which their interior provides a sheltered locus for nucleation of calcium-containing mineral crystals including HA (2, FINAL ACCEPTED VERSION C-00320-2003.R2 (16, 18, 27) , ATPase (18) , Na + K + ATPase (8) and the sodium-dependent P i -transporter Pit-1/Glvr-1 (15) . The enrichment of TNAP in MVs (by ~1-2 logs) relative to the plasma membrane and whole cells is a fundamental feature of MVs that contributes substantially to MV promineralizing activity (1, 18, 22, 27) . However, TNAP activity in MVs is balanced partly by the capacity of MVs to generate and retain PP I , an inhibitor of HA crystal nucleation and propagation (16, 22, 43) .
NPP activity is enriched by more than one log in MVs relative to the plasma membrane and whole cells (11, 23) . Prior work has identified that NPP1 is targeted to MVs in a preferential manner relative to NPP2 and NPP3 (23, 24) . Furthermore, NPP1 directly antagonizes the mineralizing function of TNAP in MVs and vice versa (22) . In specific, osteoblasts of NPP1 knockout mice have depressed extracellular and MVs PP i levels, and enhanced MV-mediated mineralization in vitro and hyperostosis in vivo, defects corrected by concurrent TNAP gene deletion (16) . The primary objective of this study was to evaluate how the critical calcificationregulating NPP activity concentrates in the osteoblast plasma membrane and MVs.
NPP1 and NPP3 are class II transmembrane glycoproteins with highly homologous extracellular domains, but with no significant homology in the primary sequence of their short intracellular cytoplasmic segments (7, 13 ). Thus, we tested the hypothesis that the molecular basis for NPP1 concentration with MVs was attributable to a distinct region in the cytosolic tail of NPP1. Previous studies have identified the NPP1 cytosolic di-leucine motif to be critical in basolateral membrane targeting of NPP1 in polarized epithelial cells and NPP3 lacks such a dileucine containing cytosolic motif (5) . Results of this study uncover the signal used by osteoblasts to target and concentrate functional NPP activity to the plasma membrane and subsequently into MVs where NPP1 regulates PP i concentration and mineralization.
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EXPERIMENTAL PROCEDURES
Isolation of NPP1 knock out mice osteoblasts, SaOS-2 cell culture and generation of stable cell lines -Generation and genotyping of NPP1 knock out mice was as previously described (21) . Primary cultures of NPP1 knock out and congenic wild type osteoblasts were isolated from intramembranous bone (calvariae) of 0-3 day-old pups via sequential collagenase digestion, as described (21 DNA constructs and mutagenesis -We used previously described full-length wild type NPP1
and NPP3 cDNA constructs in pcDNA3 (24) . Mutagenesis at specific sites was carried out using the QuickChange TM Site-Directed Mutagenensis kit from Stratagene (LaJolla, CA), with all mutations confirmed by sequencing. Constructions of the chimeric and NPP3/AAASLLAP constructs have been described in detail (5) . To create the reporter constructs NPP1 t/tm-GFP and NPP3 t/tm-GFP, human cDNA constructs of NPP1 and NPP3, respectively, were used as templates to PCR amplify the tail-transmembrane region of these molecules. The PCR products, validated by sequencing, were cloned into pEGFP-N1 vector (Clontech, CA). for 10 min. The amount of Alizarin Red precipitated was quantified using a previously described cetylpyridinium-based chromogenic assay ( Statistical analyses-Where indicated, error bars represent standard deviation. Statistical analyses were performed using the Student's t test (paired 2-sample testing for means).
RESULTS
Role of NPP1 cytosolic tail in MV targeting-Cell-associated NPP1 and NPP3 enzymatic activities are roughly equivalent in primary osteoblasts (21) , and NPP1 knockout mouse primary calvarial osteoblasts retain substantial cell-associated NPP activity (21) . Nevertheless, it was observed that there was ~80% depletion of NPP activity associated with MVs from NPP1 knockout osteoblasts relative to MVs derived from wild type cells (Fig. 1 ). There was no change in MV AP activity in NPP1 knockout cell-derived MVs relative to wild type cells ( To test the importance of the tail-transmembrane region of NPP1 in MV targeting, SaOS-2 cells were stably transfected with chimeras of NPP1 and NPP3 ( Fig. 2C and D) generated using rodent NPP1 and NPP3, which are highly conserved relative to their respective human forms (7, 13) . These chimeras were efficiently expressed in SaOS-2 cells and NPP activity was detected in the MVs of cells expressing the chimera bearing the NPP1 tail-transmembrane (NPP1t/tm) region (Fig. 3B ). This was not the case for the chimera bearing the NPP3 tailtransmembrane region (NPP3t/tm) with the NPP1 extracellular domain (NPP1ec).
Next, the molecular basis for the NPP1 cytosolic tail-transmembrane domain mediating 
Di-leucine cytosolic tail motif involvement in targeting NPP1 to MVs -Paired leucine
residues within the AAASLLAP motif of the wild type human NPP1 cytosolic tail at positions 49-50 were mutated by substitutions to alanine, and these constructs (schematized in Fig. 3I and J)
were stably transfected. As a control, the only other leucine in the NPP1 cytosolic tail (at position 60) was substituted to alanine (Fig. 3K ). Tyrosine residues in the cytoplasmic tail are potentially signals responsible for protein trafficking. Therefore, the sole tyrosine residue in the NPP1 cytosolic tail (position 75) was substituted to glycine ( Fig. 3L ) to test for its potential as a targeting signal. Expression of each of the site-specific mutants of the NPP1 cytosolic tail increased cellular NPP activity comparably to wild type NPP1 in stably transfected cells (Fig.   4A ). The sizes and expression levels (ranging from 10 to 13 fold stimulation over empty vector transfected cells) of the mutant proteins also were grossly comparable with wild type NPP1 (Fig.   4B ). These stable cell lines were induced to mineralize and MVs prepared from them.
Mutations in the di-leucine motif at position 49-50 blunted the increased NPP activity in MVs preparations achieved by stable wild type NPP1 expression ( Fig. 4C and D) . In contrast, cells expressing the leu60-ala and tyr75-gly mutants produced MVs with increased NPP activity in a Subcellular localization of wild type and mutant NPP1-The SaOS-2 stable cell lines were also analyzed by confocal immunofluorescence microscopy ( Fig. 5 and 6 ). Use of GFP reporter constructs with the cytosolic tail-transmembrane region of NPP1 and NPP3 (schematized in Fig.   2F and G) indicated that the tail region of NPP1was sufficient to promote localization in the plasma membrane of SaOS-2 cells (Fig. 5B ). Though punctate intracellular staining was also detected, the chimeric proteins NPP1t/tm-NPP3ec and NPP3/AAASLLAP were localized predominantly in the plasma membrane ( Fig. 5D and F) . In contrast, NPP3 t/tm-GFP remained in intracellular vesicles (Fig. 5C ). The NPP3t/tm-NPP1ec chimera also demonstrated exclusively intracellular vesicular staining (Fig. 5E ). Mutations in the di-leucine cytosolic tail motif of NPP1 attenuated localization of NPP1 to the plasma membrane. Cells expressing these mutants localized NPP1 principally to apparent intracellular vesicular structures ( Fig. 6 D and E). In contrast, the wild type NPP1, leu60-ala and tyr75-gly mutants all comparably localized predominantly to the plasma membrane ( Fig. 6 B, C and F). Thus, the NPP1 cytosolic tail and the cytosolic tail AAASLLAP motif mediated plasma membrane localization of NPP1 in SaOS-2 cells.
The punctate staining of the di-leucine amino acid mutant co-localized with the early endosomal marker EEA1 (Fig. 7B.3 ). However, no significant overlap in signal was observed with LAMP-2, a late endosome/lysosomal marker (Fig. 7 D. 3). Figs. 7A.3 and C.3 showed that wild type NPP1 was localized in the plasma membrane and no co localization with EEA1 or LAMP2 was observed. Therefore, mutations in the cytosolic di-leucine motif appeared to induce aberrant NPP1 retention in early endosomes.
FINAL ACCEPTED VERSION C-00320-2003.R2
Modulation of PP i levels and mineralization by NPP1 mutants-MV-associated PP i levels were ~50% lower in cells expressing the NPP1 cytoplasmic tail di-leucine mutants, relative to cells expressing wild type NPP1 (Fig. 8A) . Ultrastuctural morphology of MVs preparations revealed that with NPP1ala49ala50 expression, there was an abundance of electron-dense inclusions within MVs suggesting calcification (Fig. 8C) , as opposed to a paucity of such inclusions in MVs of cells expressing the MV targeted mutant NPP1leu60-ala (Fig. 8B) . Hence, the mineralizing function of NPP1 mutants was directly examined. Wild type NPP1 expression inhibited active mineralization by SaOS-2 cells, which was assessed by staining for the calciumbinding dye, Alizarin Red S and by measuring precipitated Alizarin Red S via a cetylpyridinium dye binding assay (Fig. 9 ). NPP1 mutants that were localized to MVs increased the local PP i levels and promoted decreased mineralization, in contrast to NPP1 mutants that were not targeted to MVs. Thus, the extent of targeting of NPP1 activity to MVs correlated directly with the extent of mineralization by SaOS-2 cells.
DISCUSSION
In this study, the basic mechanism and functional significance of NPP1 targeting to the plasma membrane and MVs of human osteoblastic cells were investigated. NPP1 has an essential role in regulating mineralization, as established in studies of NPP1-deficient mice that develop spontaneous calcification in a variety of PP i tissues (34, 38) . In specific, ttw/ttw mice homozygous for a NPP1 truncation mutation develop pathologic calcification in articular cartilage and the aorta, increased vertebral cortical bone formation, and peripheral joint and intervertebral ossific ankylosis (34), a phenotype recapitulated nearly identically in NPP1 knockout mice (16, 21, 38) . Furthermore, loss of NPP1 function was recently identified to be the causative factor in the human disease IIAC, characterized by pathologic large tunica media artery and periarticular calcification in early life (36, 37) .
The findings of this study established fundamental mechanisms in NPP1 action as a physiologic calcification regulator. A prerequisite for this functional capacity of NPP1 was targeting to MVs, which is not a feature of NPP2-3 (24) . A plasma membrane (and MV)
targeting signal was identified in the NPP1 but not NPP3 cytosolic tail. This signal comprised the sequence motif AAASLLAP, which is conserved across species in NPP1 (7, 13) . The paired leucine residues contained in this motif, at position 49-50 in the NPP1 cytosolic tail, were critical residues for MV targeting. Importantly, the AAASLLAP domain was also sufficient to confer de determined that the cytosolic tyrosine of NPP1 was not required for NPP1 plasma membrane targeting and MV localization in osteoblasts that regulated calcification.
In this study, we observed that NPP activity was greatly reduced in MVs of NPP1 knockout mice, as compared to MVs from congenic wild type cells. This finding was significant partly because NPP1 and NPP3 expression and specific activities appear roughly equivalent in primary osteoblasts, and the residual level of cell-associated NPP activity in NPP1 knockout mouse primary osteoblasts is not only substantial (~50% that of wild type cells in early culture) but also steadily increases in the primary osteoblasts as they mineralize in culture (21) . Confocal microscopy experiments in this study revealed that NPP1 was distributed to the plasma membrane in SaOS-2 cells, whereas NPP3 was localized predominantly intracellularly.
Very little staining of the plasma membrane was observed in NPP1 cytosolic tail di-leucine mutant expressing SaOS-2 cells. This is unlike the case in epithelial cells, where NPP1 and NPP3 are localized to basolateral and apical membranes respectively (5). Furthermore, in polarized epithelial cells, NPP1 cytosolic tail di-leucine motif mutation caused a shift in membrane localization such that NPP1 become directed to the apical plasma membrane (5).
The lack of an epithelial cell equivalent "apical membrane" in SaOS-2 cells may help explain the paucity of plasma membrane localization of the NPP1 cytosolic tail di-leucine mutant in osteoblastic cells in this study.
This study suggested that NPP1 had to be localized in the plasma membrane to be ultimately targeted to MVs. One of the mechanisms for sorting of membrane proteins in both polarized and non-polarized cells is transport directly from the trans-Golgi network (TGN) via vesicles to distinct plasma membrane surfaces (25) . Alternatively, vesicles from the TGN can be initially directed to the basolateral membrane, followed by endocytosis in recycling FINAL ACCEPTED VERSION C-00320-2003.R2
endosomes and subsequent sorting to the appropriate plasma membrane surface (25, 32) . In this process, adaptins mediate post-endocytic recycling of transmembrane proteins to the plasma membrane in a manner dependent on cytosolic di-leucine motifs, or specific tyrosinecontaining motifs (6, 25, 32 ). In the current study, NPP1 di-leucine motif mutants were retained intracellular in early endosomal vesicles in SaOS-2 cells. One possibility is that SAOS-2 cells may lack an apical targeting pathway, thus, NPP3 and the NPP1 di-leucine motif mutant could conceivably reach the plasma membrane but then be internalized and retained in endosomal 
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The only other Leu60 in the NPP1 cytoplasmic tail was changed to ala in the mutant construct NPP1leu60-ala. L. Tyr75 was substituted by gly in the mutant NPP1tyr75-gly. 
